Walgreens to offer allergy treatment Auvi-Q as EpiPen shortage persists

Walgreens Boots Alliance is set to be the first community pharmacy to offer EpiPen alternative Auvi-Q as the nation faces a shortage of the potentially life-saving devices. Auvi-Q, an epinephrine auto-injector from Kaléo, had been primarily available through its direct delivery.

Walgreens Boots Alliance is set to be the first community pharmacy to offer EpiPen alternative Auvi-Q as the nation faces a shortage of the potentially life-saving devices. Auvi-Q, an epinephrine auto-injector from Kaléo, had been primarily available through its direct delivery. Auvi-Q has a list price of $4,500, but a Kaléo spokesman says those who wish to pay cash are charged $360 for two auto-injectors and a trainer. A spokeswoman for Walgreens says its agreement with Kaléo is not exclusive.